Pancreatic Cancer Research

ResearcherCork University HospitalActive in the last 2 years

Derek Gerard Power

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6763-0005; OpenAlex author ID A5055522939. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemcitabine and NAB-paclitaxel therapy in adv… Co-author DOI 10.1186/s12885-025-14512-2↗
  2. Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial. Co-author DOI 10.1200/jco.22.01134↗
  3. Borderline resectable pancreatic adenocarcinoma, is conversion therapy realistic? Last author DOI 10.3109/0284186x.2014.887856↗
  4. Identification of distinct phenotypes of locally advanced pancreatic adenocarcinoma. Co-author DOI 10.1007/s12029-012-9419-9↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ray McDermott · 2 shared papers, 2013–2026 · strength 0.27
  2. David J. Easty · 1 shared paper, 2026 · strength 0.23
  3. Patrick Glyn Morris · 1 shared paper, 2026 · strength 0.23
  4. Bryan T. Hennessy · 1 shared paper, 2026 · strength 0.23
  5. Adrian Gerard Murphy · 1 shared paper, 2026 · strength 0.23
  6. Ciara Marie Kelly · 1 shared paper, 2014 · strength 0.05
  7. Kevin C. Conlon · 1 shared paper, 2013 · strength 0.04
  8. Paul F. Ridgway · 1 shared paper, 2013 · strength 0.04
  9. Min Yuen Teo · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.